Skip to main content
. 2021 May 10;6(3):100115. doi: 10.1016/j.esmoop.2021.100115

Figure 3.

Figure 3

Survival curves of patients with L858R and without brain metastasis.

Kaplan–Meier curves of (A) TD-TKI, (B) progression-free survival (PFS), and (C) overall survival (OS) of patients with non-small-cell lung cancer (NSCLC) harboring L858R without brain metastasis (red, the afatinib group; blue, the osimertinib group).

CI, confidence interval; HR, hazard ratio.